ACHE and Down syndrome: Donepezil, an acetylcholinesterase inhibitor, has been suggested in a clinical investigation to enhance language ability in individuals with Down syndrome who do not have dementia; however, larger-scale research is required to validate this finding (Johnson et al., 2003).